These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37491623)
1. Transcriptional upregulation of galectin-3 in multiple sclerosis. Mangano K; Petralia MC; Bella R; Pennisi M; Muñoz-Valle JF; Hernández-Bello J; Nicoletti F; Fagone P Immunol Res; 2023 Dec; 71(6):950-958. PubMed ID: 37491623 [TBL] [Abstract][Full Text] [Related]
2. Cell- and stage-specific localization of galectin-3, a β-galactoside-binding lectin, in a mouse model of experimental autoimmune encephalomyelitis. Itabashi T; Arima Y; Kamimura D; Higuchi K; Bando Y; Takahashi-Iwanaga H; Murakami M; Watanabe M; Iwanaga T; Nio-Kobayashi J Neurochem Int; 2018 Sep; 118():176-184. PubMed ID: 29920290 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 Plays a Role in Neuroinflammation in the Visual Pathway in Experimental Optic Neuritis. Funaki M; Nio-Kobayashi J; Suzuki R; Bando Y Cells; 2024 Mar; 13(7):. PubMed ID: 38607051 [TBL] [Abstract][Full Text] [Related]
4. Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration. Xue S; Lozinski BM; Ghorbani S; Ta K; D'Mello C; Yong VW; Dong Y J Neurosci; 2023 Jun; 43(25):4725-4737. PubMed ID: 37208177 [TBL] [Abstract][Full Text] [Related]
5. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis. Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992 [TBL] [Abstract][Full Text] [Related]
6. Absence of system x Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920 [TBL] [Abstract][Full Text] [Related]
7. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738 [TBL] [Abstract][Full Text] [Related]
8. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI Front Immunol; 2018; 9():2588. PubMed ID: 30464764 [TBL] [Abstract][Full Text] [Related]
10. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis. Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577 [TBL] [Abstract][Full Text] [Related]
11. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody. Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System. Ravanidis S; Poulatsidou KN; Lagoudaki R; Touloumi O; Polyzoidou E; Lourbopoulos A; Nousiopoulou E; Theotokis P; Kesidou E; Tsalikakis D; Karacostas D; Grigoriou M; Chlichlia K; Grigoriadis N Stem Cells Transl Med; 2015 Dec; 4(12):1450-62. PubMed ID: 26511651 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134 [TBL] [Abstract][Full Text] [Related]
14. Galectins and neuroinflammation. Chen HL; Liao F; Lin TN; Liu FT Adv Neurobiol; 2014; 9():517-42. PubMed ID: 25151395 [TBL] [Abstract][Full Text] [Related]
15. Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9. Madireddi S; Eun SY; Mehta AK; Birta A; Zajonc DM; Niki T; Hirashima M; Podack ER; Schreiber TH; Croft M J Immunol; 2017 Oct; 199(8):2721-2728. PubMed ID: 28877989 [TBL] [Abstract][Full Text] [Related]
16. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis. Steelman AJ; Smith R; Welsh CJ; Li J J Biol Chem; 2013 Aug; 288(33):23776-87. PubMed ID: 23836896 [TBL] [Abstract][Full Text] [Related]
17. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair. Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177 [TBL] [Abstract][Full Text] [Related]
19. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237 [TBL] [Abstract][Full Text] [Related]
20. Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins. Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y Int J Pharm; 2018 Jan; 536(1):310-317. PubMed ID: 29217470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]